Featured Article

Patient Connectivity Benefits Familial Chylomicronemia Syndrome

Patient Connectivity Benefits Familial Chylomicronemia Syndrome

Patients with familial chylomicronemia syndrome who were actively connected were also 3 times as likely to report "high" or "extremely high" motivation in managing their own health.

Latest Features

Breathing New Life Into COPD and Asthma Therapy With Statins

Breathing New Life Into COPD and Asthma Therapy With Statins

Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Statins Limit Vaccine Efficacy of Influenza Strain

Statins Limit Vaccine Efficacy of Influenza Strain

Statin use modified vaccine effectiveness and influenza risk for A(H3N2) infection but not for A(H1N1).

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Vitamin D may influence cardiovascular disease risk via its effect on lipid levels.

Considering Cardiovascular Risks of Antidiabetic Drugs

Considering Cardiovascular Risks of Antidiabetic Drugs

A review of current antidiabetic drug treatments available and their individual cardiovascular risk profiles.

PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost

PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost

PCSK9 inhibitors may offer hope to patients with familial hypercholesterolemia who cannot tolerate or achieve goal LDL-C levels with statins.

LATEST NEWS

Patient Connectivity Benefits Familial Chylomicronemia Syndrome

Patient Connectivity Benefits Familial Chylomicronemia Syndrome

Patients with familial chylomicronemia syndrome who were actively connected were also 3 times as likely to report "high" or "extremely high" motivation in managing their own health.

Idiopathic inflammatory myositis linked to statin exposure

In a case-control study, patients with histologically-confirmed idiopathic inflammatory myositis were more likely to report exposure to statin medications than population-matched controls.

Statin Prescribing Has Increased With Automated Patient Dashboard

Statin Prescribing Has Increased With Automated Patient Dashboard

Modest increase in statin prescribing with automated dashboard using active choice framing for primary care physicians.

Unfavorable Prepregnancy Lipid Levels Linked to Low Parity

Unfavorable Prepregnancy Lipid Levels Linked to Low Parity

Higher prepregnancy triglyceride levels and triglyceride high-density lipoprotein cholesterol ratios were linked to increased risk for one lifetime pregnancy.

Preeclampsia, Gestational Hypertension Increases CVD Risk Later in Life

Preeclampsia, Gestational Hypertension Increases CVD Risk Later in Life

Women with preeclampsia or gestational hypertension during their first pregnancy were more likely to report increased rates of subsequent chronic hypertension, type 2 diabetes, and hypercholesterolemia compared with women who were normotensive.

Statin Use and Cardiovascular Risk Perception Varies Among Races

Statin Use and Cardiovascular Risk Perception Varies Among Races

African American patients were less likely than white patients to be treated with any statin and at the guideline-recommended intensity.

Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes

Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes

To understand the mechanism underlying the benefit of fenofibrate on vascular complications in patients with type 2 diabetes, investigators assessed carotid intima thickness as a marker of subclinical atherosclerosis.

Many AKI Reports in FAERS Linked to Drugs Not Recognized as Nephrotoxic

Many AKI Reports in FAERS Linked to Drugs Not Recognized as Nephrotoxic

According to the authors, this is the first study to identify medications most commonly reported for a specific adverse reaction using this database.

Increased Arterial Stiffness Observed in Patients With Systemic Lupus Erythematosus

Increased Arterial Stiffness Observed in Patients With Systemic Lupus Erythematosus

Patients with systemic lupus erythematosus exhibit increased central arterial stiffness compared with a healthy control population.

LDL-C Reduction Examined With Different Evolocumab Dosing Regimens

LDL-C Reduction Examined With Different Evolocumab Dosing Regimens

For this study, researchers investigated the pharmacodynamics of evolocumab in two Phase 2 placebo-controlled studies (MENDEL and LAPLACE-TIMI 57) in order to determine which dosing regimens provided the most consistent LDL-C reduction.

Sign Up for Free e-Newsletters